Signaling mechanisms of the epithelial-mesenchymal transition
Open accessThe DOI matches its Crossref record; 264 of the 266 references it cites were found in a registry or an index.
Abstract
Signals from the microenvironment trigger epithelial-mesenchymal transition in development and disease through multiple, crosstalking pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have shown that dysregulated Wnt signaling promotes the proliferation of fibroblasts and myofibroblasts in the penile tissue, contributing to the excessive deposition of collagen and other ECM components.”
From Research advances in Peyronie's disease: a comprehensive review on genomics, pathways, phenotypic manifestation, and therapeutic targets. (2024) · cites this paper as [49]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Several signalling pathways, such as the TGFβ signalling pathway, the Wnt/ β -catenin signalling pathway, and the integrin signalling pathway, play important roles in EMT induction [34].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Wang, Z., Banerjee, S., Li, Y., Rahman, K. M. W., Zhang, Y., & Sarkar, F. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4281 · Cited by 307
RetractedRETRACTED: Lysyl Oxidase-like 2 Deaminates Lysine 4 in Histone H3
Herranz, N., Dave, N., Millanes‐Romero, A., Morey, L., Diaz, V. M., Lorenz, V., Gallego, R. G., Jerónimo, C., Croce, L. D., de Herreros, A. G., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.03.002 · Cited by 80
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196 · cited 15×
“Y. Shintani, M. A. Hollingsworth, M. J. Wheelock, K. R. Johnson, Collagen I promotes metastasis in pancreatic cancer by activating c-Jun NH2-terminal kinase 1 and up-regulating N-cadherin expression.”
BackgroundInfluentialEpithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091 · cited 2×
“Adhesion to both the basement membrane and adjacent cells is critical for maintaining the epithelial phenotype (10).”
BackgroundCell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Complex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958
Cited by
Items 101–200 of 1,001
Andriani, F., Bertolini, G., Facchinetti, F., Baldoli, E., Moro, M., Casalini, P., Caserini, R., Milione, M., Leone, G., Pelosi, G., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2015.10.002 · Cited by 113
Wu, D.-M., Zhang, T., Liu, Y.-B., Deng, S.-H., Han, R., Liu, T., Li, J., & Xu, Y. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1591-4 · Cited by 109
The Role of the IL-6 Cytokine Family in Epithelial–Mesenchymal Plasticity in Cancer Progression
Abaurrea, A., Araujo, A. M., & Caffarel, M. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158334 · Cited by 117
PRMT5 activates AKT via methylation to promote tumor metastasis
Huang, L., Zhang, X.-O., Rozen, E. J., Sun, X., Sallis, B., Verdejo‐Torres, O., Wigglesworth, K., Moon, D., Huang, T., Cavaretta, J. P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31645-1 · Cited by 119
Zhou, P., Li, Y., Li, B., Zhang, M., Liu, Y., Yao, Y., & Li, D. (2019) · Oncogene · doi:10.1038/s41388-019-0806-6 · Cited by 108
Marlar, S., Jensen, H. H., Login, F. H., & Nejsum, L. N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102106 · Cited by 107
The roles of the COX2/PGE2/EP axis in therapeutic resistance
Tong, D., Liu, Q., Wang, L.-A., Xie, Q., Pang, J., Huang, Y., Wang, L., Liu, G., Zhang, D., Lan, W., et al. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9752-y · Cited by 111
BMP signaling and its paradoxical effects in tumorigenesis and dissemination
Zhang, L., Ye, Y., Long, X., Xiao, P. G., Ren, X., & Yu, J. (2016) · Oncotarget · doi:10.18632/oncotarget.12151 · Cited by 122
Mi, Y., Zhang, D., Jiang, W., Weng, J., Zhou, C., Huang, K., Tang, H., Yu, Y., Liu, X., Cui, W., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.12.033 · Cited by 105
An insight into novel therapeutic potentials of taxifolin
Liu, Y., Shi, X., Tian, Y., Zhai, S., Liu, Y., Xiong, Z., & Chu, S. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1173855 · Cited by 118
Dong, T., Zhang, Y., Chen, Y., Liu, P., An, T., Zhang, J., Yang, H., Zhu, W., & Yang, X. (2016) · Oncotarget · doi:10.18632/oncotarget.13786 · Cited by 112
Duan, H., Yan, Z., Chen, W., Wu, Y., Han, J., Guo, H., & Qiao, J. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.08.010 · Cited by 113
An Overview of Vasculogenic Mimicry in Breast Cancer
Andonegui-Elguera, M. A., Alfaro‐Mora, Y., Cáceres-Gutiérrez, R. E., Caro-Sánchez, C. H. S., Herrera, L. A., & Díaz‐Chávez, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00220 · Cited by 109
Yang, Z., Guo, L., Liu, D., Sun, L., Chen, H., Deng, Q., Liu, Y., Yu, M., Ma, Y.-F., Guo, N., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.3241 · Cited by 105
Liu, L., Sun, Q., Davis, F., Mao, J., Zhao, H., & Ma, D. (2022) · Burns & Trauma · doi:10.1093/burnst/tkac011 · Cited by 98
The therapeutic potential of targeting the endothelial-to-mesenchymal transition
Man, S., Sánchez‐Duffhues, G., ten Dijke, P., & Baker, D. A. (2018) · Angiogenesis · doi:10.1007/s10456-018-9639-0 · Cited by 105
Zhang, C., Zeng, Y., Guo, X., Shen, H., Zhang, J., Wang, K., Ji, M., & Huang, S. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.923737 · Cited by 114
Tang, H., Gao, L., Mao, J., He, H., Liu, J., Cai, X., Lin, H., & Wu, T. (2015) · Cell Stress and Chaperones · doi:10.1007/s12192-015-0654-4 · Cited by 105
Su, Y., Hopfinger, N. R., Nguyen, T. D., Pogash, T. J., Santucci-Pereira, J., & Russo, J. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0988-8 · Cited by 105
Yoshida, T., Song, L., Bai, Y., Kinose, F., Li, J., Ohaegbulam, K. C., Muñoz-Antonia, T., Qu, X., Eschrich, S., Uramoto, H., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0147344 · Cited by 96
PM2.5, Fine Particulate Matter: A Novel Player in the Epithelial-Mesenchymal Transition?
Xu, Z., Ding, W., & Deng, X. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01404 · Cited by 101
Regulation of cancer stem cells in triple negative breast cancer
Fultang, N., Chakraborty, M., & Peethambaran, B. (2021) · Cancer Drug Resistance · doi:10.20517/cdr.2020.106 · Cited by 125
Sistigu, A., Modugno, F. D., Manic, G., & Nisticò, P. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.05.008 · Cited by 111
Alterations in Epithelial Cell Polarity During Endometrial Receptivity: A Systematic Review
Whitby, S., Zhou, W., & Dimitriadis, E. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.596324 · Cited by 102
Noncanonical role of transferrin receptor 1 is essential for intestinal homeostasis
Chen, A. C., Donovan, A., Ned, R. M., & Andrews, N. C. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511701112 · Cited by 98
Lee, H.-M., Hwang, K., & Choi, K. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.12.026 · Cited by 107
Avrahami, D., Wang, Y. J., Schug, J., Feleke, E., Gao, L., Liu, C., Naji, A., Gläser, B., & Kaestner, K. H. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101057 · Cited by 103
Downregulation of E-cadherin in pluripotent stem cells triggers partial EMT
Aban, C. E., Lombardi, A., Neiman, G., Biani, M. C., La Greca, A., Waisman, A., Moro, L. N., Sevlever, G., Miriuka, S., & Luzzani, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-81735-1 · Cited by 95
Mahaki, H., Nobari, S., Tanzadehpanah, H., Babaeizad, A., Kazemzadeh, G., Mehrabzadeh, M., Valipour, A., Yazdinezhad, N., Manoochehri, H., Yang, P., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118023 · Cited by 111
Ito, T., Kudoh, S., Ichimura, T., Fujino, K., Hassan, W. A., & Udaka, N. (2016) · Human Cell · doi:10.1007/s13577-016-0149-3 · Cited by 102
A Review on Annona muricata and Its Anticancer Activity
Ilango, S., Sahoo, D. K., Paital, B., Kathirvel, K., Gabriel, J. I., Subramaniam, K., Jayachandran, P., Dash, R. K., Hati, A. K., Behera, T. R., et al. (2022) · Cancers · doi:10.3390/cancers14184539 · Cited by 91
Lv, X., Li, L., Lv, L., Qu, X., Jin, S., Li, K., Deng, X., Cheng, L., He, H., & Dong, L. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0245-3 · Cited by 97
RetractedHelium/Argon-Generated Cold Atmospheric Plasma Facilitates Cutaneous Wound Healing
Lou, B., Hsieh, J. H., Chen, C., Hou, C.-W., Wu, H.-Y., Chou, P., Lai, C., & Lee, J. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00683 · Cited by 96
Relevance of Notch Signaling for Bone Metabolism and Regeneration
Ballhause, T. M., Jiang, S., Baranowsky, A., Brandt, S., Mertens, P. R., Frosch, K., Yorgan, T. A., & Keller, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031325 · Cited by 101
The Role of TGF-β in Bone Metastases
Trivedi, T., Pagnotti, G. M., Guise, T. A., & Mohammad, K. S. (2021) · Biomolecules · doi:10.3390/biom11111643 · Cited by 108
Morphological single cell profiling of the epithelial–mesenchymal transition
Leggett, S. E., Sim, J. Y., Rubins, J. E., Neronha, Z. J., Williams, E. K., & Wong, I. Y. (2016) · Integrative Biology · doi:10.1039/c6ib00139d · Cited by 106
Molecular mechanisms of epithelial to mesenchymal transition in tumor metastasis
Nieszporek, A., Skrzypek, K., Adamek, G., & Majka, M. (2019) · Acta Biochimica Polonica · doi:10.18388/abp.2019_2899 · Cited by 111
Targeting the Notch and TGF-β signaling pathways to prevent retinal fibrosis in vitro and in vivo
Fan, J., Shen, W., Lee, S., Mathai, A. E., Zhang, R., Xu, G., & Gillies, M. C. (2020) · Theranostics · doi:10.7150/thno.45192 · Cited by 94
Yuan, R., Fan, Q., Liang, X., Han, S., He, J., Wang, Q.-Q., Gao, H., Feng, Y., & Yang, S. (2022) · Chinese Medicine · doi:10.1186/s13020-022-00581-z · Cited by 97
Yang, S.-W., Zhang, Z.-G., Hao, Y.-X., Zhao, Y.-L., Qian, F., Shi, Y., Li, P.-A., Liu, C.-Y., & Yu, P.-W. (2017) · Oncotarget · doi:10.18632/oncotarget.14484 · Cited by 87
Luo, J., Chen, J., Li, H., Yu, Y., Yun, H., Yang, S., & Mao, X. (2017) · Oncology Letters · doi:10.3892/ol.2017.6886 · Cited by 89
Wnt Signalling in Acute Myeloid Leukaemia
Gruszka, A. M., Valli, D., & Alcalay, M. (2019) · Cells · doi:10.3390/cells8111403 · Cited by 78
Endothelial-mesenchymal transition in atherosclerotic lesion calcification
Boström, K. I., Yao, J., Guihard, P. J., Blázquez‐Medela, A. M., & Yao, Y. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.046 · Cited by 91
Circ_0026344 restrains metastasis of human colorectal cancer cells via miR-183
Shen, T., Cheng, X., Liu, X., Xia, C., Zhang, H., Pan, D., Zhang, X., & Li, Y. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1669620 · Cited by 94
Cancer cells remodel themselves and vasculature to overcome the endothelial barrier
Shenoy, A. K., & Lu, J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.10.031 · Cited by 92
Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axis
Lin, C.-W., Wang, L.-K., Wang, S.-P., Chang, Y.-L., Wu, Y.-Y., Chen, H.-Y., Hsiao, T.-H., Lai, W.-Y., Lu, H.-H., Chang, Y.-H., et al. (2016) · Nature Communications · doi:10.1038/ncomms13867 · Cited by 86
“merging evidence has shown that the hypoxic nature of the tumour microenvironment is closely associated with late-stage cancer progression and metastasis 1,2 .”
Tian, S., Yang, Y., Liu, X., & Xu, Q. (2018) · Medical Science Monitor · doi:10.12659/msm.905496 · Cited by 86
Tight Junction Protein Signaling and Cancer Biology
Nehme, Z., Roehlen, N., Dhawan, P., & Baumert, T. F. (2023) · Cells · doi:10.3390/cells12020243 · Cited by 97
Pillai, S., Trevino, J. G., Rawal, B., Singh, S., Kovacs, M. A., Li, X., Schell, M. J., Haura, E. B., Bepler, G., & Chellappan, S. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-0681 · Cited by 85
Perron, G., Jandaghi, P., Solanki, S., Safisamghabadi, M., Storoz, C., Karimzadeh, M., Papadakis, A. I., Arseneault, M., Scélo, G., Banks, R. E., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.031 · Cited by 100
Apigenin: Molecular Mechanisms and Therapeutic Potential against Cancer Spreading
Naponelli, V., Rocchetti, M. T., & Mangieri, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105569 · Cited by 102
Zhang, L., Zhang, W., Li, Y., Alvarez, A. A., Li, Z., Wang, Y., Song, L., Lv, D., Nakano, I., Hu, B., et al. (2016) · Oncogene · doi:10.1038/onc.2016.100 · Cited by 89
Du, P., Zeng, H., Xiao, Y., Zhao, Y., Zheng, B., Deng, Y., Liu, J., Huang, B., Zhang, X., Yang, K., et al. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-02981-1 · Cited by 81
Epithelial–Mesenchymal Plasticity in Tumor Immune Evasion
Mullins, R. D. Z., Pal, A., Barrett, T. F., Neal, M. E. H., & Puram, S. V. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-4370 · Cited by 92
Li, H., Xu, F., Li, S., Zhong, A., Meng, X., & Lai, M. (2016) · Cell Adhesion & Migration · doi:10.1080/19336918.2015.1129481 · Cited by 94
Amphiphilic Drug Conjugates as Nanomedicines for Combined Cancer Therapy
Gao, C., Bhattarai, P., Chen, M., Zhang, N., Hameed, S., Yue, X., & Dai, Z. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00692 · Cited by 88
LncRNA MALAT1 modulates ox-LDL induced EndMT through the Wnt/β-catenin signaling pathway
Li, H., Zhao, Q., Chang, L., Wei, C., Bei, H., Yin, Y., Chen, M., Wang, H., Liang, J., & Wu, Y. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1006-7 · Cited by 88
Li, H., Li, J., Zhang, G., Da, Q., Chen, L., Yu, S., Zhou, Q., Weng, Z., Xin, Z., Shi, L., et al. (2019) · Theranostics · doi:10.7150/thno.30578 · Cited by 89
Modelling the complex nature of the tumor microenvironment: 3D tumor spheroids as an evolving tool
Rodrigues, D. B., Reis, R. L., & Pirraco, R. P. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-00997-9 · Cited by 94
Jiang, B., Zhang, T., Liu, F., Sun, Z., Shi, H., Hua, D., & Yang, C. G. (2016) · Oncotarget · doi:10.18632/oncotarget.9035 · Cited by 87
Xu, R., Zhu, X., Chen, F., Huang, C., Ai, K., Wu, H., Zhang, L., & Zhao, X. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0540-0 · Cited by 83
A “NOTCH” Deeper into the Epithelial-To-Mesenchymal Transition (EMT) Program in Breast Cancer
Kar, R., Jha, N. K., Jha, S. K., Sharma, A., Dholpuria, S., Asthana, N., Chaurasiya, K., Singh, V. K., Burgee, S., & Nand, P. (2019) · Genes · doi:10.3390/genes10120961 · Cited by 88
Sun, L., Xing, J., Zhou, X., Song, X., & Gao, S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116685 · Cited by 102
González-Foruria, I., Santulli, P., Chouzenoux, S., Carmona, F., Chapron, C., & Batteux, F. (2017) · MHR: Basic science of reproductive medicine · doi:10.1093/molehr/gax028 · Cited by 80
Chilosi, M., Caliò, A., Rossi, A., Gilioli, E., Pedica, F., Montagna, L., Pedron, S., Confalonieri, M., Doglioni, C., Ziesche, R., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.147 · Cited by 85
Zhao, S., Sun, H., Jiang, W., Mi, Y., Zhang, D., Wen, Y., Cheng, D., Tang, H., Wu, S., Yu, Y., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0585-z · Cited by 79
Cao, Y. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0188-9 · Cited by 94
Kang, E., Seo, J., Yoon, H., & Cho, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073591 · Cited by 90
Anticancer Effects and Molecular Mechanisms of Apigenin in Cervical Cancer Cells
Chen, Y., Wu, J.-X., Yang, S., Yang, C.-K., Chen, T.-H., & Hsiao, Y.-H. (2022) · Cancers · doi:10.3390/cancers14071824 · Cited by 82
The strategies to cure cancer patients by eradicating cancer stem-like cells
Mai, Y., Su, J., Yang, C., Xia, C., & Fu, L. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01867-y · Cited by 82
Wnt/Planar Cell Polarity Signaling: New Opportunities for Cancer Treatment
Daulat, A. M., & Borg, J. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.01.001 · Cited by 82
Feng, J., Dong, C., Long, Y., Mai, L., Ren, M., Li, L., Zhou, T., Yang, Z., Ma, J., Li, Y., et al. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0376-9 · Cited by 81
tRNA-derived small RNAs in human cancers: roles, mechanisms, and clinical application
Zhou, M., He, X., Zhang, J., Mei, C., Zhong, B., & Ou, C. (2024) · Molecular Cancer · doi:10.1186/s12943-024-01992-2 · Cited by 90
Su, L., Luo, Y., Yang, Z., Yang, H. J., Yao, C., Cheng, F., Shan, J., Chen, J., Li, F., Liu, L., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0246 · Cited by 78
Sirtuin 1 attenuates nasal polypogenesis by suppressing epithelial-to-mesenchymal transition
Lee, M., Kim, D. W., Yoon, H., So, D., Khalmuratova, R., Rhee, C., Park, J., & Shin, H. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.07.026 · Cited by 80
Gu, J., Cui, C.-F., Li, Y., Wang, L., & Jiang, X. (2018) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504018x15150662230295 · Cited by 76
RetractedFarzaneh, Z., Vosough, M., Agarwal, T., & Farzaneh, M. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01924-w · Cited by 89
Crosas-Molist, E., Bertran, E., Rodriguez-Hernandez, I., Herraiz, C., Cantelli, G., Fabra, À., Sanz-Moreno, V, & Fabregat, I. (2017) · Oncogene · doi:10.1038/onc.2016.454 · Cited by 78
Teo, W., Chen, H., Huang, J. C., & Chan, Y. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4135 · Cited by 82
Wang, C., Ruan, P., Zhao, Y., Li, X., Wang, J., Wu, X., Liu, T., Wang, S., Hou, J., Li, Q., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13582 · Cited by 78
RetractedOhshima, J., Wang, Q., Fitzsimonds, Z. R., Miller, D. P., Sztukowska, M. N., Jung, Y.-J., Hayashi, M., Whiteley, M., & Lamont, R. J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1900101116 · Cited by 78
Hu, Y., Qi, C., Liu, X., Zhang, C., Gao, J., Wu, Y., Yang, H. J., Zhao, Q., Li, J., Wang, X., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.04.034 · Cited by 80
Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy
Gu, Y., Zhang, Z., & ten Dijke, P. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-00980-8 · Cited by 79
Immunosuppressive Traits of the Hybrid Epithelial/Mesenchymal Phenotype
Sahoo, S., Nayak, S. P., Hari, K., Purkait, P., Mandal, S., Kishore, A., Levine, H., & Jolly, M. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.797261 · Cited by 83
Yoo, J., Kwak, S.-Y., An, H., Bae, I., Park, M. J., & Han, Y. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.04.016 · Cited by 74
CPEB1 mediates epithelial-to-mesenchyme transition and breast cancer metastasis
Nagaoka, K., Fujii, K., Zhang, H., Usuda, K., Watanabe, G., Ivshina, M. P., & Richter, J. D. (2015) · Oncogene · doi:10.1038/onc.2015.350 · Cited by 79
Chen, Y., Yuan, T., Zhang, H., Yan, Y., Wang, D., Fang, L., Lü, Y., & Du, G. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.20316 · Cited by 80
Withaferin A inhibits Epithelial to Mesenchymal Transition in Non-Small Cell Lung Cancer Cells
Kyakulaga, A. H., Aqil, F., Munagala, R., & Gupta, R. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-34018-1 · Cited by 74
Progress and challenges of sequencing and analyzing circulating tumor cells
Zhu, Z., Qiu, S., Shao, K., & Hou, Y. (2017) · Cell Biology and Toxicology · doi:10.1007/s10565-017-9418-5 · Cited by 78
The Paradox of Cancer Immune Exclusion: Immune Oncology Next Frontier
Pai, S. I., Cesano, A., & Marincola, F. M. (2020) · Cancer treatment and research · doi:10.1007/978-3-030-38862-1_6 · Cited by 81
Song, S., Zhang, R., Cao, W., Fang, G., Yu, Y., Wan, Y., Wang, C., Li, Y., & Wang, Q. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27583 · Cited by 77
Liu, T., Xu, P., Ke, S., Dong, H., Zhan, M., Hu, Q., & Li, J. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.109087 · Cited by 78
Epithelial–Mesenchymal Transition Mechanisms in Chronic Airway Diseases: A Common Process to Target?
Mottais, A., Riberi, L., Falco, A., Soccal, S., Gohy, S. T., & Rose, V. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512412 · Cited by 76
Merčnik, M. H., Schliefsteiner, C., Sánchez‐Duffhues, G., & Wadsack, C. (2024) · Human Reproduction Update · doi:10.1093/humupd/dmae007 · Cited by 83
Early SRC activation skews cell fate from apoptosis to senescence
Anerillas, C., Herman, A. B., Rossi, M., Munk, R., Lehrmann, E., Martindale, J. L., Cui, C.-Y., Abdelmohsen, K., De, S., & Gorospe, M. (2022) · Science Advances · doi:10.1126/sciadv.abm0756 · Cited by 71
MACC1—the first decade of a key metastasis molecule from gene discovery to clinical translation
Radhakrishnan, H., Walther, W., Zincke, F., Kobelt, D., Imbastari, F., Erdem, M., Kortüm, B., Dahlmann, M., & Stein, U. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9771-8 · Cited by 83
Mottaghi, S., & Abbaszadeh, H. (2021) · Phytotherapy Research · doi:10.1002/ptr.7270 · Cited by 76
Błaszczak, E., Miziak, P. A., Odrzywolski, A., Baran, M. T., Gumbarewicz, E., & Stepulak, A. (2025) · Cancers · doi:10.3390/cancers17020228 · Cited by 82
Du, D., Katsuno, Y., Meyer, D. S., Budi, E. H., Chen, S., Koeppen, H., Wang, H., Akhurst, R. J., & Derynck, R. (2017) · EMBO Reports · doi:10.15252/embr.201744250 · Cited by 82
Bandeira, F., Goh, T.-W., Setiawan, M., Yam, G. H., & Mehta, J. S. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1533-1 · Cited by 78
Metadata
- Authors
- Gonzalez, D. M., & Medici, D.
- Affiliations
- Brown University (US)
- Corresponding author
- Gonzalez, David M.
- Medici, Damian
- Venue
- Science Signaling
- Published
- 2014-09-23
- Volume
- 7
- Issue
- 344
- Pages
- re8-re8
- ISSN
- 1937-9145 (ISSN-L)
- 1945-0877
- PMC
- PMC4372086
- OpenAlex
- W1963501822
- Cited by
- 1,721
- References
- 266
- Citations by year
- 2026: 66 · 2025: 132 · 2024: 164 · 2023: 167 · 2022: 201 · 2021: 224 · 2020: 188 · 2019: 159 · 2018: 120 · 2017: 117 · 2016: 109 · 2015: 62 · 2014: 8
- FWCI
- 11.21
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Signaling (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL112860)
- National Institute of General Medical Sciences (P20GM104937)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- epithelial-mesenchymal transition, endothelial-to-mesenchymal transition, signaling pathways, TGF-beta, bone morphogenetic proteins, Wnt/β-catenin signaling, Notch signaling, Hedgehog signaling, receptor tyrosine kinase, transcription factors, cell-cell adhesion, cytoskeletal dynamics, extracellular matrix, hypoxia, fibrosis, metastasis, tissue regeneration, embryonic development
- MeSH terms
- Animals, Cell Adhesion, Cytoskeleton, Extracellular Matrix, Fibrosis, Gene Expression Regulation, Humans, Neoplasm Metastasis, Neoplasm Proteins, Neoplasms, Phenotype, Transcription Factors, Transcription, Genetic, Signal Transduction, Cell Hypoxia, Cell Adhesion Molecules, Receptor Cross-Talk, Receptor Protein-Tyrosine Kinases, Intercellular Signaling Peptides and Proteins, Embryonic Development, Epithelial-Mesenchymal Transition, Cellular Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.